Personalized Medicine in Ovarian Cancer: A Perspective From Mexico.
Luis E Fernandez-GarzaIrma G Dominguez-VigilJose Garza-MartinezErick A Valdez-AparicioSilvia A Barrera-BarreraHugo Alberto Barrera SaldañaPublished in: World journal of oncology (2021)
Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for treating each patient relying on "omic" tools to match the correct drug with the specific pathogenic genomic signature. PM can help predict the best therapeutic option for each affected woman suffering from OC. In recent years, Mexico has made contributions to the PM of OC; however, it still has a long way to go for its full implementation in the country's health system.
Keyphrases
- particulate matter
- air pollution
- end stage renal disease
- healthcare
- polycyclic aromatic hydrocarbons
- heavy metals
- newly diagnosed
- ejection fraction
- case report
- primary care
- chronic kidney disease
- public health
- prognostic factors
- peritoneal dialysis
- emergency department
- type diabetes
- gene expression
- polycystic ovary syndrome
- quality improvement
- patient reported
- health information
- copy number
- skeletal muscle
- metabolic syndrome
- social media
- health promotion